• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home Posts Dermatology

Category Archive

  • Dermatology / December 28, 2020

    Drug interactions of natural supplements in dermatology: a review.

    View Post
  • Dermatology / June 11, 2021

    Interpretation of genomic sequence variants in genetic skin diseases: A primer for clinicians.

    View Post
  • Dermatology / May 2, 2021

    Primary cutaneous T-cell lymphomas other than Mycosis Fungoides and Sezary Syndrome – Part I: Clinical and histologic features and diagnosis.

    View Post
  • Dermatology / January 29, 2021

    Diagnosing Atopic Dermatitis in Infancy Using Established Diagnostic Criteria: A Cohort Study.

    View Post
  • Dermatology / November 20, 2020

    A de novo missense mutation of CYLD gene with multiple familial trichoepithelioma.

    View Post

The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa; results of a prospective European cohort study.

In Dermatology
by ClinOwl
January 23, 2021

Tetracyclines and clindamycin plus rifampicin combination therapy are both considered first-line therapy in current Hidradenitis Suppurativa (HS) guidelines. However, evidence for their efficacy is drawn from small studies, often without …

Validity and reliability of Patient-Reported Outcomes Measurement Information System Global Health scale in adults with atopic dermatitis.

In Dermatology
by ClinOwl
January 23, 2021

Patient-Reported Outcomes Measurement Information System Global Health (PGH) was validated to assess health-related quality of life (HRQOL) in several diseases. Little is known about its measurement properties in adult atopic …

Bromhidrosis Treatment Modalities: A Literature Review.

In Dermatology
by ClinOwl
January 22, 2021

Treatment options for Bromhidrosis include Botulinum toxin therapy, microwave-based therapy, laser therapy, and surgerical intervention. There have been limited studies comparing their efficacies.The purpose of this literature review is to …

Small molecule inhibitors and biologics in treating nail psoriasis: a systematic review and network meta-analysis.

In Dermatology
by ClinOwl
January 22, 2021

Various systemic immunomodulating therapies have been investigated to treat nail psoriasis, but the efficacy remains unclear.To perform a systematic review and network meta-analysis (NMA) to evaluate the efficacy of small …

An Evidence-Based Guide to SARS-CoV-2 Vaccination of Patients on Immunotherapies in Dermatology.

In Dermatology
by ClinOwl
January 22, 2021

Immune-mediated diseases and immunotherapeutics can negatively impact normal immune functioning and consequently vaccine safety and response. The COVID-19 pandemic has incited research aimed at developing a novel SARS-CoV-2 vaccine. As …

The risk of systemic infections requiring hospitalisation in children with atopic dermatitis: a Danish retrospective nationwide cohort study.

In Dermatology
by ClinOwl
January 21, 2021

Certain infections can trigger worsening of atopic dermatitis (AD). Further, an increased risk of extra-cutaneous infections has been suggested among children with AD, but data are sparse.To examine whether hospital …

Age-Appropriate Cancer Screening: A Cohort Study of Adults with Psoriasis Prescribed Biologics, Adults in the General Population, and Adults with Hypertension.

In Dermatology
by ClinOwl
January 20, 2021

Psoriasis is associated with increased risk of developing and dying from cancer.To evaluate whether psoriasis patients prescribed biologics receive the recommended screening for cervical, breast, and colon cancer.We conducted a …

Analysis of 3702 patients with acne vulgaris and concomitant comorbidities in Turkey: a multi-centered, prospective, controlled study.

In Dermatology
by ClinOwl
January 20, 2021

Acne vulgaris is a chronic inflammatory skin disease that affects the pilosebaceous unit. Although it is considered to be a skin-limited disease, different clinical studies have recently been published in …

Diet and acne: review of the evidence from 2009 to 2020.

In Dermatology
by ClinOwl
January 19, 2021

Dietary habits may play a non-negligible role in the development, duration, and severity of acne, as shown in past critical review articles on such association.The aim of this systematic review …

Antihistamine Safety in Older Adult Dermatologic Patients.

In Dermatology
by ClinOwl
January 19, 2021

Twenty percent of Americans will be over age 65 by 2030,1 and without a dedicated geriatrics curriculum in many residency trainings programs, dermatologists may be less familiar with age-associated side …

  • Page 33 of 57
  • ←
  • 1
  • ...
  • 32
  • 33
  • 34
  • ...
  • 57
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Mar    

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer